Display of Streptococcus iniae α-Enolase on the Surface of Virus-Like Particles (VLPs) of Nervous Necrosis Virus (NNV) Using SpyTag/SpyCatcher

被引:0
作者
Jeong In Yang
Ki Hong Kim
机构
[1] Pukyong National University,Department of Aquatic Life Medicine
来源
Marine Biotechnology | 2022年 / 24卷
关键词
Nervous necrosis virus; Virus-like particle; SpyTag/SpyCatcher; Surface display; Antigen delivery;
D O I
暂无
中图分类号
学科分类号
摘要
Virus-like particle (VLP)-based vaccines are promising candidates for overcoming the safety problems of live vaccines and weak immunogenicity of subunit vaccines. VLPs can be used as a platform for the development of combined vaccines by expressing foreign antigens, and foreign antigens can be displayed on the surface of VLPs by conjugation. In the present study, to use nervous necrosis virus (NNV) VLPs as a delivery tool for Streptococcus iniae α-enolase by displaying on the VLP’s surface, the split-intein (SpyTag/SpyCatcher) conjugation system was used. NNV capsid protein fused to SpyTag (Capsid-SpyTag) and S. iniae α-enolase fused to SpyCatcher (α-enolase-SpyCatcher) were recombinantly produced, then mixed in various ratios. A ratio of Capsid-SpyTag to α-enolase-SpyCatcher of 1 to 1.5 showed the highest coupling efficiency corresponding to 83–92% of coupled capsid protein dimer and 32–52% of coupled capsid protein monomer. In TEM observation, VLP of Capsid-SpyTag had a regular shape and size of about 40 nm, while VLP fused with α-enolase-SpyCatcher showed an irregular shape and size of about 40–50 nm in diameter. In preliminary immunization experiments, olive flounder (Paralichthys olivaceus) and zebrafish (Danio rerio) immunized with VLP fused with α-enolase-SpyCatcher showed the lowest cumulative mortality against S. iniae infection.
引用
收藏
页码:1066 / 1072
页数:6
相关论文
共 180 条
[1]  
Adams A(2019)Progress, challenges and opportunities in fish vaccine development Fish Shellfish Immunol 90 210-214
[2]  
Brune KD(2016)Plug-and-display: decoration of virus-like particles via isopeptide bonds for modular immunization Sci Rep 6 1-13
[3]  
Leneghan DB(2007)Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease Immunol Res 39 225-239
[4]  
Brian IJ(2002)Determinants of autoantibody induction by conjugated papillomavirus virus-like particles J Immunol 169 6120-6126
[5]  
Ishizuka AS(2018)Oral immunization with cell-free self-assembly virus-like particles against orange-spotted grouper nervous necrosis virus in grouper larvae, Epinephelus coioides Vet Immunol Immunopathol 197 69-75
[6]  
Bachmann MF(2012)Virus-like particles: the new frontier of vaccines for animal viral infections Vet Immunol Immunopathol 148 211-225
[7]  
Draper SJ(2009)Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease Nat Med 15 34-41
[8]  
Biswas S(2018)Virus-like particle vaccines: immunology and formulation for clinical translation Expert Rev Vaccines 17 833-849
[9]  
Howarth M(2020)Virus like particles (VLP) as multivalent vaccine candidate against chikungunya, Japanese encephalitis, yellow fever and Zika virus Sci Rep 10 1-13
[10]  
Castilow EM(2019)Catching a SPY: using the SpyCatcher-SpyTag and related systems for labeling and localizing bacterial proteins Int J Mol Sci 20 2129-57